Cargando…
Changes in the frequencies of Plasmodium falciparum dhps and dhfr drug-resistant mutations in children from Western Kenya from 2005 to 2018: the rise of Pfdhps S436H
BACKGROUND: Sulfadoxine-pyrimethamine (SP) is the only anti-malarial drug formulation approved for intermittent preventive treatment in pregnancy (IPTp). However, mutations in the Plasmodium falciparum dhfr (Pfdhfr) and dhps (Pfdhps) genes confer resistance to pyrimethamine and sulfadoxine, respecti...
Autores principales: | Pacheco, M. Andreína, Schneider, Kristan A., Cheng, Qiuying, Munde, Elly O., Ndege, Caroline, Onyango, Clinton, Raballah, Evans, Anyona, Samuel B., Ouma, Collins, Perkins, Douglas J., Escalante, Ananias A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7583259/ https://www.ncbi.nlm.nih.gov/pubmed/33092587 http://dx.doi.org/10.1186/s12936-020-03454-8 |
Ejemplares similares
-
Differences in selective pressure on dhps and dhfr drug resistant mutations in western Kenya
por: McCollum, Andrea M, et al.
Publicado: (2012) -
Human NCR3 gene variants rs2736191 and rs11575837 alter longitudinal risk for development of pediatric malaria episodes and severe malarial anemia
por: Onyango, Clinton O., et al.
Publicado: (2023) -
Differential Gene Expression in Host Ubiquitination Processes in Childhood Malarial Anemia
por: Anyona, Samuel B., et al.
Publicado: (2021) -
Nonsynonymous amino acid changes in the α-chain of complement component 5 influence longitudinal susceptibility to Plasmodium falciparum infections and severe malarial anemia in kenyan children
por: Raballah, Evans, et al.
Publicado: (2022) -
Entire Expressed Peripheral Blood Transcriptome in Pediatric Severe Malarial Anemia
por: Anyona, Samuel, et al.
Publicado: (2023)